ClinicalTrials.Veeva

Menu

Node and Atrial Fibrillation Ablation for Persistent Atrial Fibrillation (NAFAPAF)

E

Eastbourne General Hospital

Status

Unknown

Conditions

Persistent Atrial Fibrillation

Treatments

Procedure: AV node ablation
Procedure: AF ablation and AV node ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT01057485
NAFAPAFv1.3

Details and patient eligibility

About

The purpose of the study is to assess combining AF ablation, with AV node ablation and pacemaker implantation for patients suffering with 'irregular heartbeats' or atrial fibrillation. The study will last 13 months.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with symptomatic drug refractory atrial fibrillation.
  • Patients who have had pacemaker implantation and AV node ablation with ongoing symptoms.
  • Patients will already be refractory to at least 2 rate or rhythm control drugs.
  • Patients must be over 18 years old.
  • Patients give informed consent form prior to participating in this study.

Exclusion criteria

  • Patient is suffering with unstable angina in last 1 week.
  • Patient has had a myocardial infarction within last 2 months.
  • Patient is expecting or has had major cardiac surgery within last 2 months.
  • Patient is participating in a conflicting study.
  • Patient is unable to perform exercise testing.
  • Patient is mentally incapacitated and cannot consent or comply with follow-up.
  • Patient has NYHA class III/ IV heart failure.
  • Patient has LVEF <35% not secondary to tachycardia.
  • Pregnancy.
  • Patient suffers with other cardiac rhythm disorders.
  • Recent coronary artery intervention or other factors suggesting clinical instability (ECG, clinical or laboratory findings).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

AF ablation and AV node ablation
Experimental group
Description:
Patients will receive the combined procedure of AF ablation as well as AV node ablation
Treatment:
Procedure: AF ablation and AV node ablation
AV node ablation
Active Comparator group
Description:
Patient will receive AV node ablation alone
Treatment:
Procedure: AV node ablation

Trial contacts and locations

1

Loading...

Central trial contact

Steven J Podd, MBBS, MA, MRCP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems